These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18251358)

  • 1. Absorption of vaginal estrogen cream during sexual intercourse: a prospective, randomized, controlled trial.
    Hurst BS; Jones AI; Elliot M; Marshburn PB; Matthews ML
    J Reprod Med; 2008 Jan; 53(1):29-32. PubMed ID: 18251358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of one-week treatment with vaginal estrogen preparations on serum estrogen levels in postmenopausal women.
    Labrie F; Cusan L; Gomez JL; Côté I; Bérubé R; Bélanger P; Martel C; Labrie C
    Menopause; 2009; 16(1):30-6. PubMed ID: 18820592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
    Gupta P; Ozel B; Stanczyk FZ; Felix JC; Mishell DR
    Menopause; 2008; 15(1):94-7. PubMed ID: 17882008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized comparison of tolterodine with vaginal estrogen cream versus tolterodine alone for the treatment of postmenopausal women with overactive bladder syndrome.
    Tseng LH; Wang AC; Chang YL; Soong YK; Lloyd LK; Ko YJ
    Neurourol Urodyn; 2009; 28(1):47-51. PubMed ID: 19089890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sexual absorption of vaginal progesterone: a randomized control trial.
    Merriam KS; Leake KA; Elliot M; Matthews ML; Usadi RS; Hurst BS
    Int J Endocrinol; 2015; 2015():685281. PubMed ID: 25713585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open-label randomized trial to determine the most effective regimen of vaginal estrogen to reduce the prevalence of atrophic changes reported in postmenopausal cervical smears.
    Bateson DJ; Weisberg E
    Menopause; 2009; 16(4):765-9. PubMed ID: 19407678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration.
    Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Bérubé R; Bélanger P; Berger L; Gilbert L; Martel C; Balser J
    Menopause; 2009; 16(5):897-906. PubMed ID: 19436226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twice-weekly synthetic conjugated estrogens vaginal cream for the treatment of vaginal atrophy.
    Freedman M; Kaunitz AM; Reape KZ; Hait H; Shu H
    Menopause; 2009; 16(4):735-41. PubMed ID: 19252451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized study of low-dose conjugated estrogens on sexual function and quality of life in postmenopausal women.
    Gast MJ; Freedman MA; Vieweg AJ; De Melo NR; Girão MJ; Zinaman MJ;
    Menopause; 2009; 16(2):247-56. PubMed ID: 19034054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of ultralow-dose transdermal estradiol on sexual function in postmenopausal women.
    Huang A; Yaffe K; Vittinghoff E; Kuppermann M; Addis I; Hanes V; Quan J; Grady D
    Am J Obstet Gynecol; 2008 Mar; 198(3):265.e1-7. PubMed ID: 18313446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saliva versus serum estradiol: implications for research studies using postmenopausal women.
    Tivis LJ; Richardson MD; Peddi E; Arjmandi B
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):727-32. PubMed ID: 15944139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the route of estrogen administration on insulinlike growth factor-I, IGF binding protein-3, and insulin resistance in healthy postmenopausal women: results from a randomized, controlled study.
    Davis SR; Stuckey BG; Norman RJ; Papalia MA; Drillich A; Bell RJ
    Menopause; 2008; 15(6):1065-9. PubMed ID: 18806686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized comparison of lower and standard dosages of transdermal estradiol on serum estradiol levels and vaginal maturation index.
    Rungruxsirivorn T; Panyakamlerd K; Trerattanachart S; Taechakraichana N
    J Med Assoc Thai; 2006 Sep; 89(9):1362-7. PubMed ID: 17100370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women.
    Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Berger L; Gilbert L; Martel C; Balser J
    Menopause; 2009; 16(5):923-31. PubMed ID: 19424093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absorption, bioavailability, and partner transfer of estradiol from a topical emulsion.
    Taylor MB; Gutierrez MJ
    Pharmacotherapy; 2008 Jun; 28(6):712-8. PubMed ID: 18503399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allopregnanolone serum concentrations and neurosteroid sensitivity during withdrawal from postmenopausal hormone therapy.
    Wihlbäck AC; Nyberg S; Andersson A; Bixo M; Bäckström T; Sundström-Poromaa I
    Gynecol Endocrinol; 2007 Oct; 23(10):590-6. PubMed ID: 17852417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short term changes in melatonin and cortisol serum levels after a single administration of estrogen to menopausal women.
    Kerdelhué B; Andrews MC; Zhao Y; Scholler R; Jones HW
    Neuro Endocrinol Lett; 2006 Oct; 27(5):659-64. PubMed ID: 17159819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double-blind, placebo-controlled study.
    Dinsmore WW; Wyllie MG
    BJU Int; 2009 Apr; 103(7):940-9. PubMed ID: 19245438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, placebo-controlled trial to assess the safety and acceptability of use of carraguard vaginal gel by heterosexual couples in Thailand.
    Kilmarx PH; Blanchard K; Chaikummao S; Friedland BA; Srivirojana N; Connolly C; Witwatwongwana P; Supawitkul S; Mock PA; Chaowanachan T; Tappero J
    Sex Transm Dis; 2008 Mar; 35(3):226-32. PubMed ID: 18490865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose 17-β-estradiol cream for vaginal atrophy in a cohort without prolapse: Serum levels and vaginal response including tissue biomarkers associated with tissue remodeling.
    Illston JD; Wheeler TL; Parker CR; Conner MG; Burgio KL; Goode PS; Richter HE
    Maturitas; 2015 Aug; 81(4):475-9. PubMed ID: 26115591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.